(Q50497689)

14 March 2018

title

Amyloid aggregation of lysozyme: the synergy study of red wine polyphenols. (English)

1 reference

14 March 2018

1 reference

1 reference

Zuzana Gazova

1

1 reference

14 March 2018

Katarina Siposova

2

1 reference

14 March 2018

Elena Kurin

3

1 reference

14 March 2018

Pavel Mučaji

4

1 reference

14 March 2018

Milan Nagy

5

1 reference

14 March 2018

language of work or name

English

0 references

publication date

27 February 2013

1 reference

14 March 2018

published in

Proteins

1 reference

14 March 2018

volume

81

1 reference

14 March 2018

issue

6

1 reference

14 March 2018

page(s)

994-1004

1 reference

14 March 2018

Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Conformational constraints for amyloid fibrillation: the importance of being unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Molecular pathways to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Designing conditions for in vitro formation of amyloid protofilaments and fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Effects of salt concentration on association of the amyloid protofilaments of hen egg white lysozyme studied by time-resolved neutron scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

The structural basis of protein folding and its links with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Natural products as a source of Alzheimer's drug leads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

The red wine hypothesis: from concepts to protective signalling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

SwissDock, a protein-small molecule docking web service based on EADock DSS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

UCSF Chimera--a visualization system for exploratory research and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

A possible role for pi-stacking in the self-assembly of amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

The molecular mechanisms of the anti-amyloid effects of phenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

A highly amyloidogenic region of hen lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Synergistic, additive, and antagonistic effects of food mixtures on total antioxidant capacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Resveratrol protects against global cerebral ischemic injury in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Coffee drinking influences plasma antioxidant capacity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24250

21 January 2018

Identifiers

DOI

10.1002/PROT.24250

1 reference

14 March 2018

1 reference

14 March 2018